Q&A clinic on Substance, Organisation, Referentials Management Services - February 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 10 February 2026, 11:00 (CET) to 10 February 2026, 12:00 (CET)

Submitted by Anonymous (not verified) on 2 December 2025 - 9:15

Q&A clinic on Substance, Organisation, Referentials Management Services - February 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 10 February 2026, 11:00 (CET) to 10 February 2026, 12:00 (CET)

Q&A clinic on Substance, Organisation, Referentials Management Services - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 April 2026, 11:00 (CEST) to 14 April 2026, 12:00 (CEST)

Submitted by Anonymous (not verified) on 2 December 2025 - 9:15

Q&A clinic on Substance, Organisation, Referentials Management Services - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 April 2026, 11:00 (CEST) to 14 April 2026, 12:00 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2026, 11:00 (CEST) to 12 May 2026, 12:00 (CEST)

Submitted by Anonymous (not verified) on 2 December 2025 - 9:15

Q&A clinic on Substance, Organisation, Referentials Management Services - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2026, 11:00 (CEST) to 12 May 2026, 12:00 (CEST)

SPOR and XEVMPD status update webinar - Q3 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2026, 10:00 (CEST) to 8 July 2026, 12:30 (CEST)

Submitted by Anonymous (not verified) on 2 December 2025 - 9:00

SPOR and XEVMPD status update webinar - Q3 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2026, 10:00 (CEST) to 8 July 2026, 12:30 (CEST)

SPOR and XEVMPD status update webinar - Q4 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 7 October 2026, 10:00 (CEST) to 7 October 2026, 12:30 (CEST)

Submitted by Anonymous (not verified) on 2 December 2025 - 9:00

SPOR and XEVMPD status update webinar - Q4 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 7 October 2026, 10:00 (CEST) to 7 October 2026, 12:30 (CEST)

Human medicines European public assessment report (EPAR): Rasagiline Viatris (previously Rasagiline Mylan), rasagiline, Date of authorisation: 04/04/2016, Revision: 11, Status: Authorised

Submitted by Anonymous (not verified) on 1 December 2025 - 16:15

Human medicines European public assessment report (EPAR): Rasagiline Viatris (previously Rasagiline Mylan), rasagiline, Date of authorisation: 04/04/2016, Revision: 11, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness